BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapeutics targeting RAS and PI3Kα malignancies, which are prevalent oncogenes in human tumors. Initially formed as a ...
FY 2025
Mar 5, 2026
Q3 2025
Nov 12, 2025
Q2 2025
Aug 1, 2025
Q3 2024
Nov 14, 2024
Q1 2024
May 15, 2024
